Skip to content

Inspection Record

Joinn Laboratories Co. Ltd. — FDA 483 Findings

US FDAInspected 2013-09-20Published 2026-01-22 3 findingsOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The study director failed to assure that the protocol, including any change, was approved and followed.

2Other quality system

The QAU failed to review the final study report to assure that the reported results accurately reflect the raw data ofthe study.

3Other quality system

The study director failed to assure that all raw data, documentation, protocols, specimens, and final reports were rt transferred to the archives during or at the close of the study.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-01-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Joinn Laboratories Co. Ltd. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.